siJnk2-LNP treatment led to improved architecture of the hepatic parenchyma associated with minor signs of steatosis, a reduction of well-differentiated HCCs and significantly less premalignant dysplastic nodules, associated with significantly decreased liver serum ALT levels (Fig. 5b, c, Supplementary Fig. 4a). This evidence concerns the gene GPT and steatosis.